Massimo Massaia
Massimo Massaia
Associate Professor Hematology
Verified email at
TitleCited byYear
A comparison of allografting with autografting for newly diagnosed myeloma
B Bruno, M Rotta, F Patriarca, N Mordini, B Allione, F Carnevale-Schianca, ...
New England Journal of Medicine 356 (11), 1110-1120, 2007
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25–into CD25+ T regulatory cells
A Curti, S Pandolfi, B Valzasina, M Aluigi, A Isidori, E Ferri, V Salvestrini, ...
Blood 109 (7), 2871-2877, 2007
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial
A Palumbo, S Bringhen, MT Petrucci, P Musto, F Rossini, M Nunzi, ...
Blood 104 (10), 3052-3057, 2004
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
R Piva, B Ruggeri, M Williams, G Costa, I Tamagno, D Ferrero, V Giai, ...
Blood 111 (5), 2765-2775, 2008
Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
M Coscia, E Quaglino, M Iezzi, C Curcio, F Pantaleoni, C Riganti, I Holen, ...
Journal of cellular and molecular medicine 14 (12), 2803-2815, 2010
Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease
R Foa, M Massaia, S Cardona, AG Tos, A Bianchi, C Attisano, A Guarini, ...
Blood 76 (2), 393-400, 1990
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy
M Massaia, P Borrione, S Battaglio, S Mariani, E Beggiato, P Napoli, ...
Blood 94 (2), 673-683, 1999
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
D Rossi, L Terzi-di-Bergamo, L De Paoli, M Cerri, G Ghilardi, A Chiarenza, ...
Blood 126 (16), 1921-1924, 2015
Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol‐anchored lymphocyte differentiation antigen ecto‐5′‐nucleotidase (CD73).
LF Thomson, JM Ruedi, A Glass, G Moldenhauer, P Moller, MG Low, ...
Tissue Antigens 35 (1), 9-19, 1990
Effector γδ T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma
S Mariani, M Muraro, F Pantaleoni, F Fiore, B Nuschak, S Peola, ...
Leukemia 19 (4), 664, 2005
Antitumor vaccination: where we stand
M Bocchia, V Bronte, MP Colombo, A De Vincentiis, M Di Nicola, G Forni, ...
Haematologica 85 (11), 1172-1206, 2000
Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy
V Squadrone, M Massaia, B Bruno, F Marmont, M Falda, C Bagna, ...
Intensive care medicine 36 (10), 1666-1674, 2010
Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients
R FoÓ, I Del Giudice, A Cuneo, G Del Poeta, S Ciolli, F Di Raimondo, ...
American journal of hematology 89 (5), 480-486, 2014
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma
L Giaccone, B Storer, F Patriarca, M Rotta, R Sorasio, B Allione, ...
Blood 117 (24), 6721, 2011
Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes
DD Ma, TA Sylwestrowicz, S Granger, M Massaia, R Franks, G Janossy, ...
The Journal of Immunology 129 (4), 1430, 1982
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2, 3-dioxygenase
A Curti, M Aluigi, S Pandolfi, E Ferri, A Isidori, V Salvestrini, I Durelli, ...
Leukemia 21 (2), 353, 2007
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia
D Rossi, CL Bodoni, E Genuardi, L Monitillo, D Drandi, M Cerri, ...
Leukemia 23 (6), 1062, 2009
New drugs for treatment of multiple myeloma
B Bruno, M Rotta, L Giaccone, M Massaia, A Bertola, A Palumbo, ...
The Lancet Oncology 5 (7), 430-442, 2004
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid
F Fiore, B Castella, B Nuschak, R Bertieri, S Mariani, B Bruno, ...
Blood 110 (3), 921-927, 2007
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italianá…
G Barosi, M Boccadoro, M Cavo, P Corradini, M Marchetti, M Massaia, ...
haematologica 89 (6), 717-741, 2004
The system can't perform the operation now. Try again later.
Articles 1–20